Houston-based Harris Health has selected  Capsa Healthcare, a medical equipment provider and process designer, to significantly expand its central pharmacy capacity. 

Idaho, Missouri and Kansas have been granted permission to file a lawsuit aimed at restricting access to the abortion medication mifepristone, The Hill reported Jan. 16. 

CMS has named 15 additional prescription drugs, including diabetes medication Ozempic, for price negotiations under the Inflation Reduction Act. This marks the second round of negotiations aimed at reducing drug costs for Medicare beneficiaries. 

Recent changes to the federal 340B drug discount program have led to cost increases for low-income patients and the community health clinics that serve them, The New York Times reported Jan. 16. 

An analysis of the Inflation Reduction Act of 2022 found that a majority of Medicare Part D enrollees will see lower total out-of-pocket costs in 2025. 

HHS and the Drug Enforcement Administration have finalized a rule that expands telemedicine prescribing of buprenorphine for opioid use disorder, while also proposing a new special registration process for prescribing controlled substances remotely. 

A new report from HHS' Office of Inspector General raises concerns about the FDA's accelerated approval process for drugs with weak supporting evidence, Bloomberg reported Jan. 14. 

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report.

Historically, hospitals were the most lucrative work setting for pharmacy technicians. Ambulatory healthcare services have now taken that spot, according to data from the Bureau of Labor Statistics. 

The latest data from the American Society of Health-System Pharmacists reports that the active number of drug shortages in the U.S. has decreased to 271, down from a high of 323 in the first quarter of 2024.